Skip to content

Globus Medical Reports First Quarter 2026 Results

Globus Medical, Inc. reported a strong start to 2026 with a 27% increase in overall revenue and record earnings for the first quarter ended March 31, 2026. The company attributed growth to share gains and increased procedural volume in core spine. GAAP net income rose 64.7% year-over-year to $124.3 million, while diluted EPS increased to $0.90. Globus reaffirms its full-year revenue guidance and has updated its non-GAAP EPS guidance for the year.

AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026.